Other Titles
Special Session
Abstract
Session presented on Friday, July 24, 2015:
Most longitudinal studies of symptoms in patients with chronic medical conditions report means scores and standard deviations to describe changes in symptom occurrence or severity over time. However, most clinicians know that a large amount of inter-individual variability exists in patients' reports of their symptom experiences. For example, in oncology patients receiving chemotherapy, while some patients report very few symptoms, other patients report every conceivable symptom with the highest severity scores. It is important for clinicians to be able to identify these high risk patients in order to target more aggressive symptom management interventions. In order to be able to identify patients are higher risk for a more severe symptom burden, nurse researchers need to use statistical procedures that go beyond the simple reporting of means and standard deviations. Newer approaches to the analysis of longitudinal data, including hierarchical linear modeling and latent class analysis, provide methods to identify patients who are at higher risk for a more severe symptom burden. In addition, the demographic, clinical, and molecular characteristics that are associated with increased risk can be determined. If these risk factors are confirmed in future studies, they can be used to build predictive risk models that will assist clinicians to pre-emptively identify high risk patients. The focus for this presentation is to describe these newer methods of longitudinal data analysis using the symptoms of fatigue and sleep disturbance by oncology patients as the exemplars. Fatigue and sleep disturbance are common symptoms in patients with a variety of a chronic medical conditions. Therefore, using these two symptoms as exemplars will provide information to both clinicians and researchers on the most common phenotypic and molecular characteristics associated with the most severe levels of fatigue and sleep disturbance. As part of this presentation, the purposes for using hierarchical linear modeling and latent class analysis will be compared and contrasted. In addition, approaches for integrating molecular markers into symptom management research will be discussed. This presentation will assist clinicians to perform better assessments of symptoms in patients with chronic conditions. In addition, it should provide essential information to guide the development of future symptom management studies.
Sigma Membership
Unknown
Type
Presentation
Format Type
Text-based Document
Study Design/Type
N/A
Research Approach
N/A
Keywords:
Symptom Management, Sleep Disturbance, Fatigue
Recommended Citation
Miaskowski, Christine, "Moving from the means to the standard deviations in symptom management research" (2016). INRC (Congress). 243.
https://www.sigmarepository.org/inrc/2015/presentations_2015/243
Conference Name
26th International Nursing Research Congress
Conference Host
Sigma Theta Tau International
Conference Location
San Juan, Puerto Rico
Conference Year
2015
Rights Holder
All rights reserved by the author(s) and/or publisher(s) listed in this item record unless relinquished in whole or part by a rights notation or a Creative Commons License present in this item record.
All permission requests should be directed accordingly and not to the Sigma Repository.
All submitting authors or publishers have affirmed that when using material in their work where they do not own copyright, they have obtained permission of the copyright holder prior to submission and the rights holder has been acknowledged as necessary.
Acquisition
Proxy-submission
Moving from the means to the standard deviations in symptom management research
San Juan, Puerto Rico
Session presented on Friday, July 24, 2015:
Most longitudinal studies of symptoms in patients with chronic medical conditions report means scores and standard deviations to describe changes in symptom occurrence or severity over time. However, most clinicians know that a large amount of inter-individual variability exists in patients' reports of their symptom experiences. For example, in oncology patients receiving chemotherapy, while some patients report very few symptoms, other patients report every conceivable symptom with the highest severity scores. It is important for clinicians to be able to identify these high risk patients in order to target more aggressive symptom management interventions. In order to be able to identify patients are higher risk for a more severe symptom burden, nurse researchers need to use statistical procedures that go beyond the simple reporting of means and standard deviations. Newer approaches to the analysis of longitudinal data, including hierarchical linear modeling and latent class analysis, provide methods to identify patients who are at higher risk for a more severe symptom burden. In addition, the demographic, clinical, and molecular characteristics that are associated with increased risk can be determined. If these risk factors are confirmed in future studies, they can be used to build predictive risk models that will assist clinicians to pre-emptively identify high risk patients. The focus for this presentation is to describe these newer methods of longitudinal data analysis using the symptoms of fatigue and sleep disturbance by oncology patients as the exemplars. Fatigue and sleep disturbance are common symptoms in patients with a variety of a chronic medical conditions. Therefore, using these two symptoms as exemplars will provide information to both clinicians and researchers on the most common phenotypic and molecular characteristics associated with the most severe levels of fatigue and sleep disturbance. As part of this presentation, the purposes for using hierarchical linear modeling and latent class analysis will be compared and contrasted. In addition, approaches for integrating molecular markers into symptom management research will be discussed. This presentation will assist clinicians to perform better assessments of symptoms in patients with chronic conditions. In addition, it should provide essential information to guide the development of future symptom management studies.